AVITA Medical, Inc. (RCEL)
NASDAQ
Healthcare
Medical - Devices
$4.16
▼ -0.72%
Market Cap
$103.3M
Sector
Healthcare
Industry
Medical - Devices
Beta
1.90
52-Wk Range
3.22-7.12
CEO
Cary G. Vance
Country
US
Currency
USD
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells u…
Open full interactive analysis & DCF →